Inhibition of prostaglandins and angiotensin II: effects on renal function in hypertensive patients.
Fommei
E
E
CNR Institute of Clinical Physiology, University of Pisa, Italy.
Ghione
S
S
Palla
L
L
Ragazzini
A
A
Gazzetti
P
P
Palombo
C
C
Giaconi
S
S
D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000502:physiology*; D002216:Captopril / Q000494:pharmacology; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D006978:Hypertension, Renovascular / Q000000981:diagnostic imaging / Q000503:physiopathology*; D007052:Ibuprofen / Q000494:pharmacology; D007668:Kidney / Q000503:physiopathology*; D009942:Organometallic Compounds; D004369:Pentetic Acid; D011448:Prostaglandin Antagonists / Q000494:pharmacology; D011453:Prostaglandins / Q000502:physiology*; D011877:Radionuclide Imaging; D012083:Renin / Q000097:blood; D016284:Technetium Tc 99m Pentetate
D009942:Organometallic Compounds; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D000804:Angiotensin II; D004369:Pentetic Acid; D002216:Captopril; D012083:Renin; D016284:Technetium Tc 99m Pentetate; D007052:Ibuprofen